Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis

Overview

Journal Trop Med Infect Dis

Specialty Infectious Diseases

Date 2020 May 21

PMID 32429038

Citations 85

Authors

Tope Oyelade

Jaber Alqahtani

Gabriele Canciani

Affiliations

Soon will be listed here.

Abstract

The mortality and severity in COVID-19 is increased in patients with comorbidities. The aim of this study was to evaluate the severity and mortality in COVID-19 patients with underlying kidney and liver diseases. We retrieved data on the clinical features and primary composite end point of COVID-19 patients from Medline and Embase which had been released from inception by the April 16, 2020. The data on two comorbidities, liver diseases and chronic kidney disease, were pooled and statistically analysed to explain the associated severity and mortality rate. One hundred and forty-two abstracts were screened, and 41 full articles were then read. In total, 22 studies including 5595 COVID-19 patients were included in this study with case fatality rate of 16%. The prevalence of liver diseases and chronic kidney disease (CKD) were 3% (95% CI; 2-3%) and 1% (95% CI; 1-2%), respectively. In patients with COVID-19 and underlying liver diseases, 57.33% (43/75) of cases were severe, with 17.65% mortality, while in CKD patients, 83.93% (47/56) of cases were severe and 53.33% (8/15) mortality was reported. This study found an increased risk of severity and mortality in COVID-19 patients with liver diseases or CKD. This will lead to better clinical management and inform the process of implementing more stringent preventative measures for this group of patients.

Citing Articles

Recent advancements in traditional Chinese medicine for COVID-19 with comorbidities across various systems: a scoping review.

Shang X, Cao Y, Guo Y, Zhang L, Li J, Zhang H Infect Dis Poverty. 2024; 13(1):97.

PMID: 39696533 PMC: 11658301. DOI: 10.1186/s40249-024-01263-8.

Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management.

Antar S, Ashour N, Hamouda A, Noreddin A, Al-Karmalawy A Inflammopharmacology. 2024; 32(5):2649-2680.

PMID: 39126569 DOI: 10.1007/s10787-024-01535-7.

Spectrum of COVID-19 induced liver injury: A review report.

Singh L, Kumar A, Rai M, Basnet B, Rai N, Khanal P World J Hepatol. 2024; 16(4):517-536.

PMID: 38689748 PMC: 11056898. DOI: 10.4254/wjh.v16.i4.517.

The mortality of hospitalized patients with COVID-19 and non-cirrhotic chronic liver disease: a retrospective multi-center study.

Wu P, Feng I, Lai C, Ho C, Kan W, Sheu M PeerJ. 2023; 11:e16582.

PMID: 38077441 PMC: 10702333. DOI: 10.7717/peerj.16582.

Direct impact of 2 years of COVID-19 on chronic disease patients: a population-based study in a large hard-hit Italian region.

Fortuna D, Caselli L, Berti E, Moro M BMJ Open. 2023; 13(10):e073471.

PMID: 37899159 PMC: 10619016. DOI: 10.1136/bmjopen-2023-073471.

References

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A . Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581. PMC: 7136855. DOI: 10.1001/jama.2020.5394. View

Perneger T, Whelton P, Klag M . Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med. 1994; 331(25):1675-9. DOI: 10.1056/NEJM199412223312502. View

Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C . Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606. PMC: 7224340. DOI: 10.1136/bmj.m606. View

Suleymanlar G, Utas C, Arinsoy T, Ates K, Altun B, Altiparmak M . A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study. Nephrol Dial Transplant. 2010; 26(6):1862-71. PMC: 3107767. DOI: 10.1093/ndt/gfq656. View

Orth S, Schroeder T, Ritz E, Ferrari P . Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant. 2005; 20(11):2414-9. DOI: 10.1093/ndt/gfi022. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Liu K, Chen Y, Lin R, Han K . Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020; 80(6):e14-e18. PMC: 7102640. DOI: 10.1016/j.jinf.2020.03.005. View

Wu F, Zhao S, Yu B, Chen Y, Wang W, Song Z . A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269. PMC: 7094943. DOI: 10.1038/s41586-020-2008-3. View

Song E, McClellan W, McClellan A, Gadi R, Hadley A, Krisher J . Effect of community characteristics on familial clustering of end-stage renal disease. Am J Nephrol. 2009; 30(6):499-504. PMC: 2853588. DOI: 10.1159/000243716. View

10.

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

11.

Zhang C, Shi L, Wang F . Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020; 5(5):428-430. PMC: 7129165. DOI: 10.1016/S2468-1253(20)30057-1. View

12.

Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D . Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study. Clin Infect Dis. 2020; 71(15):706-712. PMC: 7108195. DOI: 10.1093/cid/ciaa199. View

13.

Lackland D, Egan B, Fan Z, Syddall H . Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens (Greenwich). 2001; 3(1):29-31. PMC: 8101806. DOI: 10.1111/j.1524-6175.2001.00828.x. View

14.

McClellan W, Flanders W . Risk factors for progressive chronic kidney disease. J Am Soc Nephrol. 2003; 14(7 Suppl 2):S65-70. DOI: 10.1097/01.asn.0000070147.10399.9e. View

15.

Imig J, Ryan M . Immune and inflammatory role in renal disease. Compr Physiol. 2013; 3(2):957-76. PMC: 3803162. DOI: 10.1002/cphy.c120028. View

16.

Wang L, Li X, Chen H, Yan S, Li D, Li Y . Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am J Nephrol. 2020; 51(5):343-348. PMC: 7179524. DOI: 10.1159/000507471. View

17.

. Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2014; 3(1):19-62. PMC: 4089693. DOI: 10.1038/kisup.2012.64. View

18.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

19.

Goldstein S, Devarajan P . Acute kidney injury in childhood: should we be worried about progression to CKD?. Pediatr Nephrol. 2010; 26(4):509-22. DOI: 10.1007/s00467-010-1653-4. View

20.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View